Ubiquitination/ Proteasome
- Autophagy(1140)
- DUB(20)
- E1 Activating(1)
- E2 conjugating(1)
- E2 Ligases(0)
- E3 Ligase(8)
- Proteasome(106)
- p97(12)
- Mitophagy(83)
- ULK(10)
Products for Ubiquitination/ Proteasome
- Cat.No. Product Name Information
-
GC17243
Dorsomorphin (Compound C)
Compound C
Dorsomorphin (Compound C) is an agent that used as a cell-permeable AMPK inhibitor. -
GC12560
Dorsomorphin (Compound C) 2HCl
BML-275 2HCl,Compound C 2HCl
IC50: Dorsomorphin inhibited BMP4-induced phosphorylation of BMP-responsive SMADs in a dose-dependent manner (half maximal inhibitory concentration (IC50) =0.47 mM). -
GC71260
Dox-btn2
Dox-btn2 is a biotinylated derivative of Doxorubicin , with a biotin label at the point of conjugation to doxorubicin at 3'-NH2.
-
GC13443
Doxazosin Mesylate
UK 33274-27
α1-adrenergic receptor antagonist -
GC16994
Doxorubicin
Hydroxydaunorubicin
Doxorubicin(DOX), also known as adriamycin, is a compound of the anthracycline class that has the broadest spectrum of activity.
-
GC17567
Doxorubicin (Adriamycin) HCl
DOX
Doxorubicin (Hydroxydaunorubicin) hydrochloride, a cytotoxic anthracycline antibiotic, is an anti-cancer chemotherapy agent. -
GC16073
Dronedarone
An antiarrhythmic agent
-
GC12234
Dronedarone HCl
SR33589
Dronedarone HCl is a non-iodinated amiodarone derivative that inhibits Na+, K+ and Ca2+ currents. -
GC17125
DUBs-IN-2
DUBs-IN-2 is a potent deubiquitinase inhibitor with an IC50 of 0.28 μM for USP8.
-
GC10356
DUBs-IN-3
DUBs-IN-3 is a potent deubiquitinase (USP) enzyme inhibitor extracted from reference compound 22c with an IC50 of 0.56 μM for USP8.
-
GC10395
Dynasore
Dynasore, as a GTPase inhibitor, can rapidly and reversibly inhibit dynamin activity, which prevents endocytosis.
-
GC13787
E 64d
Aloxistatin, E64c ethyl ester, EP 453, EST, Loxistatin, NSC 694281
E 64d is a cell-permeable, irreversible, broad-spectrum cysteine protease inhibitor with platelet aggregation inhibitory activity. -
GC13418
E-64
E-64 is a potent and irreversible inhibitor of cysteine proteases with an IC50 of 9nM for papain.
-
GC39305
EACC
EACC is a reversible autophagy inhibitor, which can block autophagic flux.
-
GC10331
Ebselen
Ebselen is a selenoorganic compound with glutathione peroxidase-like activity and is an anti-inflammatory and antioxidant agent. Ebselen is an inhibitor of inositol monophosphatase (IMPase) with an IC50 of 1.5μM.
-
GN10564
Ecdysterone
Ecdysterone, Isoinokosterone
Ecdysterone is a naturally occurring ecdysone that controls molting (feathering) and metamorphosis in arthropods. -
GC12389
Efavirenz
DMP 266, EFV, L-743,726
Reverse transcriptase inhibitor -
GC35969
eIF4A3-IN-1
eIF4A3-IN-1 (compound 53a) is a selective eukaryotic initiation factor 4A3 (eIF4A3) inhibitor (IC50=0.26 μM; Kd=0.043 μM), which binds to a non-ATP binding site of eIF4A3 and shows significant cellular nonsense-mediated RNA decay (NMD) inhibition at 10 and 3 μM and can be as a probe for further study of eIF4A3, the exon junction complex (EJC), and NMD.
-
GC65540
eIF4A3-IN-2
eIF4A3-IN-2 is a highly selective and noncompetitive eukaryotic initiation factor 4A-3 (eIF4A3) inhibitor with an IC50 of 110 nM.
-
GC47284
Elaidic Acid-d17
C18:1(9E)-d17, 9(E)-Oleic Acid-d17, trans-Oleic Acid-d17
A neuropeptide with diverse biological activities -
GC12846
Elaiophylin
AzalomycinB, Gopalamicin, Salbomycin
Macrodiolide antibiotic -
GC10466
EMD-1214063
EMD-1214063 (Tepotinib, MSC2156119J) is a novel potent and highly selective reversible, ATP-competitive small molecule c-Met inhibitor .
-
GC43599
Emetine (hydrochloride)
An anti-protozoal drug used for intestinal and tissue amoebiasis
-
GC32048
Emetine dihydrochloride hydrate
Emetine dihydrochloride hydrate is an antigen parasite drug that can be used for the treatment of intestinal and tissue amoebic diseases.
-
GC16044
Emodin
Archin, Frangulic Acid, NSC 408120, NSC 622947, Schuttgelb
Natural CK2 inhibitor and ER agonist -
GC49124
EN219
EN219 is a moderately selective synthetic covalent ligand against an N-terminal cysteine (C8) of RNF114 with an IC50 of 470 nM. EN219 inhibits RNF114-mediated autoubiquitination and p21 ubiquitination.
-
GC35982
EN6
An activator of autophagy
-
GC15493
Enalaprilat Dihydrate
angiotensin-converting enzyme (ACE) inhibitor
-
GC11625
Entinostat (MS-275,SNDX-275)
Entinostat, SNDX 275
A histone deacetylase inhibitor -
GC14476
Entrectinib
NMS-E628, RXDX-101
Orally active inhibitor of ALK kinase -
GC72974
Entrectinib-d8
NMS-E628-d8; RXDX-101-d8
Entrectinib-d8 (NMS-E628-d8; RXDX-101-d8) is a deuterated version of Entrectinib. -
GC11499
Enzastaurin (LY317615)
LY317615
Enzastaurin (LY317615) (LY317615) is a potent and selective PKCβ inhibitor with an IC50 of 6 nM, showing 6- to 20-fold selectivity over PKCα, PKCγ and PKCε. -
GC35998
Episilvestrol
Episilvestrol is a derivative of silvestrol, isolated from the fruits and twigs of Aglaia silvestris, and is a specific eIF4A-targeting translation inhibitor, with antitumor activity.
-
GC12494
Epoxomicin
BU 4061T
Epoxomicin is a selective proteasome inhibitor that effectively inhibits the chymotrypsin-like (CH-L) activity of the 20S proteasome, with an IC50 of approximately 40-80nM. -
GC10627
Erlotinib
NSC 718781
Erlotinib is a potent and orally bioavailable epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor with an IC50 value of 2 nM. -
GC36003
Erlotinib mesylate
EGFR inhibitor
-
GC47303
Erlotinib-d6 (hydrochloride)
An internal standard for the quantification of erlotinib
-
GC10326
Erythromycin Ethylsuccinate
Macrolide antibiotic
-
GC14968
Esmolol HCl
ASL 8052
Esmolol HCl is a beta adrenergic receptor blocker. -
GC13022
Esomeprazole Magnesium trihydrate
An H+/K+-ATPase inhibitor
-
GC61669
Ethyl 3,4-dihydroxybenzoate
Ethyl 3,4-dihydroxybenzoate (Ethyl protocatechuate), an antioxidant, is a prolyl-hydroxylase inhibitor found in the testa of peanut seeds.
-
GC15617
Etoposide
VP-16; VP-16-213
Etoposide (VP-16) is a nonspecific inhibitor of topoisomerase II with an IC50 value of 59.2μM. -
GC60826
Etoposide phosphate
Etoposide phosphate (BMY-40481) is a potent anti-cancer chemotherapy agent and a selective topoisomerase II inhibitor?to prevent re-ligation of DNA strands.
-
GN10511
Eupatilin
NSC 122413
-
GC13601
Everolimus (RAD001)
RAD001
Everolimus (RAD001) is an orally active derivative of rapamycin that inhibits the Ser/Thr kinase, mTOR (mammalian target of rapamycin). -
GC15605
Ezetimibe
Ezetrol, SCH 58235
Cholesterol transport inhibitor -
GC60159
Ezetimibe ketone
Ezetimibe ketone (EZM-K) is a phase-I metabolite of Ezetimibe.
-
GC36023
FAAH inhibitor 1
Benzothiazole analog 3
FAAH inhibitor 1 (Benzothiazole analog 3) is a potent fatty acid amide hydrolase (FAAH) inhibitor with an IC50 of 18±8 nM. -
GC30751
FAAH-IN-1
FAAH-IN-1 is a fatty acid amide hydrolase (FAAH) inhibitor, with IC50s of 145 nM and 650 nM for rat and human FAAH, respectively.
-
GC30366
FAAH-IN-2
FAAH-IN-2 (O-Desmorpholinopropyl Gefitinib) is a potent FAAH(fatty acid amide hydrolase) inhibitor extracted from Patent WO/2008/100977A2.
-
GC62203
Falcarindiol
Falcarindiol, an orally active polyacetylenic oxylipin, activates PPARγ and increases the expression of the cholesterol transporter ABCA1 in cells.
-
GC38437
Fangchinoline
7-O-Demethyltetrandrine, Hanfangchin B, NSC 77036
An alkaloid with diverse biological activities -
GC13869
Fasudil
Fasudil (HA-1077; AT877) is a non-specific RhoA/ROCK inhibitor with a Ki of 0.33μM and an IC50 of 0.158μM for ROCK1, and IC50 of 4.58μM, 12.30μM, and 1.650μM for ROCK2, PKA, PKC, and PKG, respectively.
-
GC14289
Fasudil (HA-1077) HCl
Fasudil (HA-1077; AT877) Hydrochloride is a nonspecific RhoA/ROCK inhibitor and also has inhibitory effect on protein kinases, with an Ki of 0.33 μM for ROCK1, IC50s of 0.158 μM and 4.58 μM, 12.30 μM, 1.650 μM for ROCK2 and PKA, PKC, PKG, respectively. Fasudil (HA-1077) HCl is also a potent Ca2+ channel antagonist and vasodilator.
-
GC73629
FB49
FB49 is a highly selective inhibitor of Bcl-2-associated athanogene 3 (BAG3), with the Ki of 45 μM.
-
GC73307
FBnG-(Cys-acetamide)-CH2-PEG3-CH2-CH2-CH2-NH2
FBnG-(Cys-acetamide)-CH2-PEG3-CH2-CH2-CH2-NH2 is a linker of AUTAC4.
-
GC91612
FDW028
FDW028 is an inhibitor of fucosyltransferase 8 (FUC8).
-
GC17173
Felodipine
H 154/82
Selective L-type Ca2+ channel blocker -
GC71638
Felodipine-d3
Felodipine-d3 is the deuterium labeled Felodipine.
-
GC12250
Fenofibrate
PPARα agonist
-
GC17143
Fenretinide
4-HPR, 4-Hydroxy(phenyl)retinamide, MK-4016, Retinoic Acid p-hydroxyphenylamide, Ro 22-4667
A synthetic retinoic acid derivative -
GC91060
Ferritin PROTAC DeFer-2
A PROTAC that drives ferritin degradation
-
GC40484
Ferulic Acid methyl ester
Methyl Ferulate, Methyl 4'-hydroxy-3'-methoxycinnamate
Ferulic acid is a hydroxycinnamic acid that is abundant in plants and originally derived from giant fennel (F. -
GC10755
Fexaramine
farnesoid X receptor agonist
-
GC13620
FIPI
5Fluoro2Indolyl desChlorohalopemide
phosholipase D (PLD) inhibitor
-
GC70568
FiVe1
FiVe1 is a potent vimentin (VIM; the intermediate filament and mesenchymal marker) inhibitor.
-
GC15609
FK 866 hydrochloride
NMPRTase inhibitor
-
GC31563
FK-448 Free base
FK-448 Free base is an effective and specific inhibitor of chymotrypsin, with an IC50 of 720 nM.
-
GC14308
FK866 (APO866)
K 22.175
FK866 (APO866) is an inhibitor of nicotinamide phosphoribosyltransferase (NMPRTase).
-
GC16063
Flavopiridol
Alvocidib, HL 275, HMR 1275, L-868,275
An inhibitor of cyclin-dependent kinases -
GC16425
Flavopiridol hydrochloride
Alvocidib, HL 275, HMR 1275, L868,275
CDK inhibitor, potent and selective -
GC33848
Fludrocortisone acetate (9α-Fludrocortisone acetate)
9α-fluoro Hydrocortisone Acetate, NSC 15186, U 4845
Fludrocortisone acetate (9α-Fludrocortisone acetate) (9α-Fludrocortisone acetate (9α-Fludrocortisone acetate)) is a synthetic mineralocorticoid, used to control the amount of sodium and fluids in your body. -
GC33715
Fluoxetine (LY-110140)
Fluoxetine (LY-110140) is an orally active, selective serotonin reuptake inhibitor (SSRI) commonly used to treat a variety of psychiatric disorders such as depression, obsessive-compulsive disorder, and panic disorder.
-
GC11709
Fluoxetine HCl
LY110140
Serotonin reuptake inhibitor,selective -
GC10064
Flurizan
E7869, Flurizan, Tarenflurbil
A COX-inactive enantiomer of flurbiprofen -
GC13535
Fluvastatin
NSC 758896
An HMG-CoA reductase inhibitor -
GC36061
Fluvastatin D6 sodium
Fluvastatin D6 sodium (XU 62-320 D6) is deuterium labeled Fluvastatin sodium.
-
GC15541
Fluvastatin Sodium
An HMG-CoA reductase inhibitor
-
GC36063
FMK 9a
FMK 9a is an autophagin-1 inhibitor with IC50 values of 80 and 73 μM in FRET and LRA assay.
-
GC69128
Forigerimod TFA
IPP-201101 TFA
Forigerimod TFA (IPP-201101 TFA) is a CD4 T cell regulator. Forigerimod TFA is a 21 amino acid fragment of U1 small nuclear ribonucleoprotein 70 kDa, phosphorylated at the Ser140 site. Forigerimod TFA can effectively inhibit autophagy. Forigerimod TFA can be used for research on autoimmune diseases such as systemic lupus erythematosus (SLE).
-
GC11920
Forskolin
Coleonol, HL 362, L 751362B, NSC 357088, NSC 375489
Forskolin is a potent adenylyl cyclase activator with IC50 of 41 nM for type I adenylyl cyclase. -
GC32411
FR 167653 (FR 167653 sulfate)
FR 167653 sulfate
FR 167653 (FR 167653 sulfate) (FR 167653 (FR 167653 sulfate) sulfate), an orally active and selective p38 MAPK inhibitor, is a potent suppressor of TNF-α and IL-1β production via specific inhibition of p38 MAPK activity. -
GC31058
FR 167653 free base
FR 167653 free base, an orally active and selective p38 MAPK inhibitor, is a potent suppressor of TNF-α and IL-1β production via specific inhibition of p38 MAPK activity.
-
GC18000
Fulvestrant (ICI 182,780)
ICI 182780
Fulvestrant is a selective estrogen receptor (ER) antagonist. It binds, blocks and degrades estrogen receptor, then inhibits estrogen receptor(ER)-mediated transcriptional activity with an IC50 of 9.4 nM . -
GC73961
Fumagilin-105
Fumagilin-105 is an autophagy targeting chimera (AUTOTAC) that induces p62 self-oligomerization with DC50 values of 0.7 μM for MetAP2 in HEK293 cells.
-
GC90077
Furin Inhibitor I (trifluoroacetate salt)
A proprotein convertase inhibitor
-
GC13711
Gabexate mesylate
A serine protease inhibitor
-
GN10137
Galangin
NSC 407229, 3,5,7-Trihydroxyflavone
-
GC12139
Gambogic Acid
GA, β-Guttiferin
Gambogic Acid A cell-permeable caspase activator and apoptosis inducer commonly used in studies of breast, lung, and liver cancers. -
GN10109
Ganoderic Acid A
-
GC10359
GANT61
NSC 136476
GANT61 was able to efficiently block GLI1 as well as GLI2-induced transcription, IC50 is 5 µM. -
GC32739
GCN2iB
GCN2iB is an ATP-competitive inhibitor of a serine/threonine-protein kinase general control nonderepressible 2 (GCN2), with an IC50 of 2.4 nM.
-
GC12021
GDC-0349
MTOR inhibitor
-
GC10493
GDC-0449 (Vismodegib)
-
GC10816
GDC-0941
GDC-0941
A pan inhibitor of class I PI3K isoforms -
GC16154
GDC-0941 dimethanesulfonate
GDC-0941 (2 MeSO3H salt);GDC0941 dimethanesulfonate;GDC-0941;GDC0941;GDC 0941
A pan inhibitor of class I PI3K isoforms -
GC60868
Gefitinib D8
Gefitinib D8 (ZD1839 D8) is a deuterium labeled Gefitinib. Gefitinib is an EGFR tyrosine kinase inhibitor, with IC50 of 2-37 nM in NR6wtEGFR cells.
-
GC16805
Gemcitabine
DDFC, LY 188011, NSC 613327
An inhibitor of DNA synthesis
-
GC36130
Gemcitabine elaidate
CP 4126
A prodrug form of gemcitabine -
GC14447
Gemcitabine HCl
Gemcitabine HCl is a chemically synthesized deoxycytidine derivative and a DNA synthesis inhibitor that can inhibit human serum Paraoxonase 1(PON1) activity in vitro with an IC50 value of 26.610mM. In addition, Gemcitabine HCl can also be used to treat cancers such as breast cancer, bladder cancer and pancreatic cancer.